Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Part of paid clinical trials in Fort Bragg, North Carolina.
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Study ID
- NCT05049057
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Mild Traumatic Brain Injury
- Posttraumatic Headache
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 50 Years
- Healthy Volunteers
- Not accepted
Interventions
- Erenumab 140 Mg/mL Subcutaneous Solution — DRUGActive erenumab delivered via subcutaneous injection.
- Placebo — DRUGPlacebo delivered via subcutaneous injection.
Study Details
This study aims to assess the effect and safety of erenumab compared to placebo for the treatment of acute posttraumatic headache (PTH) in military service members and civilians with mild traumatic brain injury (mTBI).
Key Dates
- Start date
- Jul 19, 2022
- Status verified
- Feb 2024
- Primary completion
- May 19, 2026
- Completion
- May 19, 2027
Study Design
- Enrollment
- 404 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active DrugErenumab administered once monthly via two 70-mg subcutaneous injections at 3 time points over a 12-week period.
- Placebo Comparator: PlaceboPlacebo administered once monthly via two subcutaneous injections at 3 time points over a 12-week period.
Primary Outcome Measure
Monthly Headache Days [ Time Frame: Week 8 to Week 12 ]
Central Contacts
- Amy Guthrie, RN202-924-2729
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Womack Army Medical Center - Fort Liberty | Fort Bragg | North Carolina | 28310 | CDR Katherine Demers (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh Concussion Research Laboratory | Pittsburgh | Pennsylvania | 15203 | Anthony Kontos, MD (PRINCIPAL_INVESTIGATOR) |
| William Beaumont Army Medical Center | El Paso | Texas | 79918 | Cecilia Valdovinos, NP Sean Sebesta, MD (PRINCIPAL_INVESTIGATOR) |
| Madigan Army Medical Center | Tacoma | Washington | 98431 | Melissa Belle, NP (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Fort Bragg, NC
Related Studies
- Neuromodulation and Neurorehabilitation for mTBIRecruiting · Northwestern University · Chicago, Illinois
- Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)PHASE3 · Recruiting · VA Office of Research and Development · Birmingham, Alabama
- rTMS for Military TBI-related DepressionRecruiting · Henry M. Jackson Foundation for the Advancement of Military Medicine · Palo Alto, California
- Pathways Relating Amnestic MCI to a Mild Traumatic Brain Injury HistoryPHASE2 · Recruiting · University of Texas Southwestern Medical Center · Dallas, Texas